A Novel Mutation Substituting Tryptophan with Arginine in the Carboxyl-Terminal, Noncollagenous Domain of Collagen X in a Case of Schmid Metaphyseal Chondrodysplasia

1995 ◽  
Vol 217 (3) ◽  
pp. 1157-1162 ◽  
Author(s):  
R.K. Pokharel ◽  
H. Alimsardjono ◽  
K. Uno ◽  
S. Fujii ◽  
R. Shiba ◽  
...  
Keyword(s):  
Novel Mutation ◽  
Metaphyseal Chondrodysplasia ◽  
Carboxyl Terminal

scholarly journals A Japanese familial case of Schmid metaphyseal chondrodysplasia with a novel mutation in COL10A1

2016 ◽  
Vol 25 (3) ◽  
pp. 107-110 ◽  
Author(s):  
Shinji Higuchi ◽  
Masaki Takagi ◽  
Satoshi Shimomura ◽  
Gen Nishimura ◽  
Yukihiro Hasegawa
Keyword(s):  
Novel Mutation ◽  
Familial Case ◽  
Metaphyseal Chondrodysplasia

scholarly journals Dideoxyfingerprinting (ddF) Analysis of the Type X Collagen Gene (COL10A1) and Identification of a Novel Mutation (S671P) in a Kindred with Schmid Metaphyseal Chondrodysplasia

1996 ◽  
Vol 59 (2) ◽  
pp. 112-117 ◽  
Author(s):  
Constantine A. Stratakis ◽  
Zsolt Orban ◽  
A.Lee Burns ◽  
Alessandra Vottero ◽  
Constantine S. Mitsiades ◽  
...  
Keyword(s):  
Novel Mutation ◽  
Collagen Gene ◽  
Type X Collagen ◽  
Metaphyseal Chondrodysplasia

A novel mutation leading to elongation of the deduced α1(X) chain results in Metaphyseal Chondrodysplasia type Schmid

2011 ◽  
Vol 412 (13-14) ◽  
pp. 1266-1269 ◽  
Author(s):  
Yimin Zhu ◽  
Liping Li ◽  
Lijun Zhou ◽  
Haibo Mei ◽  
Ke Jin ◽  
...  
Keyword(s):  
Novel Mutation ◽  
Metaphyseal Chondrodysplasia

scholarly journals A Venezuelan Case of Schmid-Type Metaphyseal Chondrodysplasia with a Novel Mutation in COL10A1

2019 ◽  
Vol 10 (3) ◽  
pp. 167-170 ◽  
Author(s):  
Francisco Cammarata-Scalisi ◽  
Uta Matysiak ◽  
Tanja Velten ◽  
Michele Callea ◽  
Dianora Araque ◽  
...  
Keyword(s):  
Novel Mutation ◽  
Metaphyseal Chondrodysplasia

Congenital mirror movements in a family with a novel mutation in the DCC gene

2011 ◽  
Vol 42 (S 01) ◽  
Author(s):  
GC Korenke ◽  
M Wagner ◽  
A Maak ◽  
G Rosenberger ◽  
K Kutsche
Keyword(s):  
Novel Mutation ◽  
Mirror Movements ◽  
Dcc Gene

Danon Disease: Clinical Presentation and Diagnostic Workup in a Case of a Male Patient with a Novel Mutation in the LAMP2 Gene

2016 ◽  
Vol 47 (S 01) ◽  
Author(s):  
A. Dieckmann ◽  
F. Majer ◽  
H. Hulkova ◽  
M. Farr ◽  
T. Kalina ◽  
...  
Keyword(s):  
Male Patient ◽  
Clinical Presentation ◽  
Novel Mutation ◽  
Diagnostic Workup ◽  
Danon Disease ◽  
Lamp2 Gene

A Novel Mutation Glyl672→Arg in Type 2A and a Homozygous Mutation in Type 2B von Willebrand Disease

1996 ◽  
Vol 76 (02) ◽  
pp. 253-257 ◽  
Author(s):  
Takeshi Hagiwara ◽  
Hiroshi Inaba ◽  
Shinichi Yoshida ◽  
Keiko Nagaizumi ◽  
Morio Arai ◽  
...  
Keyword(s):  
Missense Mutation ◽  
Novel Mutation ◽  
Point Mutations ◽  
Japanese Patients ◽  
Von Willebrand Disease ◽  
Homozygous Mutation ◽  
Missense Mutations ◽  
Reaction Products ◽  
Type 3 ◽  
Von Willebrand

SummaryGenetic materials from 16 unrelated Japanese patients with von Willebrand disease (vWD) were analyzed for mutations. Exon 28 of the von Willebrand factor (vWF) gene, where point mutations have been found most frequent, was screened by various restriction-enzyme analyses. Six patients were observed to have abnormal restriction patterns. By sequence analyses of the polymerase chain-reaction products, we identified a homozygous R1308C missense mutation in a patient with type 2B vWD; R1597W, R1597Q, G1609R and G1672R missense mutations in five patients with type 2A; and a G1659ter nonsense mutation in a patient with type 3 vWD. The G1672R was a novel missense mutation of the carboxyl-terminal end of the A2 domain. In addition, we detected an A/C polymorphism at nucleotide 4915 with HaeIII. There was no particular linkage disequilibrium of the A/C polymorphism, either with the G/A polymorphism at nucleotide 4391 detected with Hphl or with the C/T at 4891 detected with BstEll.

Characterization of the Original Christmas Disease Mutation (Cysteine 206 → Serine): From Clinical Recognition to Molecular Pathogenesis

1992 ◽  
Vol 67 (01) ◽  
pp. 063-065 ◽  
Author(s):  
Sherryl A M Taylor ◽  
Jacalyn Duffin ◽  
Cherie Cameron ◽  
Jerome Teitel ◽  
Bernadette Garvey ◽  
...  
Keyword(s):  
Nucleotide Substitution ◽  
Novel Mutation ◽  
Factor Ix ◽  
Causative Mutation ◽  
Coding Region ◽  
Body Of Knowledge ◽  
Polymerase Chain ◽  
Splice Junctions

SummaryChristmas disease was first reported as a distinct clinical entity in two manuscripts published in 1952 (1, 2). The eponym associated with this disorder, is the surname of the first patient examined in detail and reported by Biggs and colleagues in a paper describing the clinical and laboratory features of seven affected individuals (3). This patient has severe factor IX coagulant deficiency (less than 0.01 units/ml) and no detectable circulating factor IX antigen (less than 0.01 units/ml). Coding sequence and splice junctions of the factor IX gene from this patient have been amplified in vitro through the polymerase chain reaction (PCR). One nucleotide substitution was identified at nucleotide 30,070 where a guanine was replaced by a cytosine. This mutation alters the amino acid encoded at position 206 in the factor IX protein from cysteine to serine. The non conservative nature of this substitution, the absence of this change in more than 200 previously sequenced factor IX genes and the fact that the remainder of the coding region of this gene was normal, all provide strong circumstantial evidence in favour of this change being the causative mutation in this patient. The molecular characterization of this novel mutation in the index case of Christmas disease, contributes to the rapidly expanding body of knowledge pertaining to Christmas disease pathogenesis.

Sign in / Sign up

Export Citation Format

Share Document